Researchers conducted an assessment of data from 16 million patients, spanning the years 2006 to 2020, who were taking semaglutide-based drugs, which include the active ingredient in Wegovy.
Study Finds Wegovy May Raise Risk of Hair Loss
Latest articles
Business
OpenAI Achieves $300bn Valuation Following $40bn SoftBank Investment Round
Roula Khalaf, the Editor of the Financial Times, curates a selection of her preferred...
Latest News
NPR’s The Picture Show
To celebrate Women's History Month, the spotlight is on Victoria Woodhull, who took a...
News
TAG Heuer’s Iconic F1 Watch: An Impressive Revamp
Last month, an early covert preview of TAG Heuer's extensive revival of its iconic...
Finance News
Intel’s New Chief Pledges ‘Cultural Change’ at Chipmaker
Roula Khalaf, Editor of the Financial Times, curates her favorite stories for a weekly...
More like this
Business
OpenAI Achieves $300bn Valuation Following $40bn SoftBank Investment Round
Roula Khalaf, the Editor of the Financial Times, curates a selection of her preferred...
Latest News
NPR’s The Picture Show
To celebrate Women's History Month, the spotlight is on Victoria Woodhull, who took a...
News
TAG Heuer’s Iconic F1 Watch: An Impressive Revamp
Last month, an early covert preview of TAG Heuer's extensive revival of its iconic...